Wenzheng Jiang

14PUBLICATIONS

13CO-AUTHORS

Molecular targetsPlasma physics; fusion plasmas; electrical dischargesMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 15, 2026

KLRG1 silencing increases the efficacy of CAR NK cell therapy against colon cancer via SHP-2/ZAP-70/NF-κB signal pathway.

|Feb 14, 2026

TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-κb signaling pathway.

Muhammad Asad Farooq, Bingtan Du, Ying Zhou

|Mar 05, 2025

GPR132 regulates the function of NK cells through the Gαs/CSK/ZAP70/NF-κB signaling pathway as a potential immune checkpoint.

Xinhui Hui, Min Xue, Yaojun Ren

|May 01, 2024

Author Correction: Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy.

Yuanhuan Yu, Xin Wu, Meiyan Wang

|Mar 27, 2024

Modulating Cholesterol Metabolism via ACAT1 Knockdown Enhances Anti-B-Cell Lymphoma Activities of CD19-Specific Chimeric Antigen Receptor T Cells by Improving the Cell Activation and Proliferation.

Qiong Su, Jie Yao, Muhammad Asad Farooq

|Aug 26, 2023

β2-Adrenergic Receptor Mediated Inhibition of T Cell Function and Its Implications for CAR-T Cell Therapy.

Muhammad Asad Farooq, Iqra Ajmal, Xinhui Hui

Pageof 3

Frequent Collaborators

Jiang Zhang

Huan Wei

Yuanhuan Yu

Xin Wu

Meiyan Wang

Wenjing Liu

Li Zhang

Ying Zhang

Qiang Zou

Fengfeng Cai

Frequent Collaborators

Jiang Zhang

Huan Wei

Yuanhuan Yu

Xin Wu